CoChat

The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.

Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review

Open access
Danborg, P.B., Valdersdorf, M., Gøtzsche, P.C. · 2019 · International Journal of Risk & Safety in Medicine

Abstract

BACKGROUND: Millions of people are treated with antidepressants like selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). This clinical practice is based on short-term trials that have exaggerated the benefits and underestimated the harms. We also know too little about long-term harms. AIM: To assess harms of SSRIs and SNRIs that persist after end of drug intake. METHODS: Systematic review of placebo-controlled randomised trials of any length in patients with a psychiatric diagnosis and a follow-up of at least six months. Our primary outcomes were mortality, functional outcomes, quality of life and core psychiatric events. We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials and checked the references for eligible articles. One researcher extracted data and another checked the data extraction. RESULTS: Our searches returned 9,153 unique records. We included 22 papers for 12 trials on SSRIs. Median intervention and follow-up periods were 15 and 52 weeks, respectively. Median number of randomised participants was 51; only two trials had a drop-out rate below 20%. Outcome reporting was less thorough during follow-up than for the intervention period and only two trials maintained the blind during follow-up. All authors concluded that the drugs were not beneficial in the long term. All trials reported harms outcomes selectively or did not report any. Only two trials reported on any of our primary outcomes (school attendance and number of heavy drinking days). CONCLUSION: The randomised trials currently available cannot be used to investigate persistent harms of antidepressants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jrs-180046

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Research works printed but not linked: 4

  1. Boesen K, 2017, Cochrane Database of Systematic Reviews, CD012857
  2. DanborgPB SimonsenAL HróbjartssonA GøtzschePC. Long-term changes in observed behavior after exposure to psychiatric drugs: A systematic review of animal studies. Published online, http://nordic.cochrane.org/sites/nordic.cochrane.org/files/public/uploads/danborg_2017_long-term_harms_animal_study.pdf
  3. SharmaT. Effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin - norepinephrine reuptake inhibitors (SNRIs) on suicidality, violence, and quality of life (PhD Thesis): University of Copenhagen; 2018.
  4. Tonge BJ, 2013, RANZCP, 47, 59

Cited by

See all 15

Metadata

Authors
Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C.
Affiliations
Rigshospitalet (DK)
Corresponding author
Gøtzsche, P.C.
Venue
International Journal of Risk & Safety in Medicine
Published
2019-05
Volume
30
Issue
2
Pages
59-71
ISSN
  • 0924-6479 (ISSN-L)
  • 1878-6847
OpenAlex
W2911290550
Cited by
14
References
57
Citations by year
2026: 3 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2
FWCI
0.16
Type
journal article
Language
en
Open access
Locations
  • International Journal of Risk & Safety in Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords
selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, antidepressants, mortality, functional outcome, quality of life, school attendance, heavy drinking, outcome reporting, trial design limitations
MeSH terms
Serotonin and Noradrenaline Reuptake Inhibitors, Long Term Adverse Effects, Depression, Humans, Selective Serotonin Reuptake Inhibitors, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review. https://app.cochat.ai/papers/10.3233/jrs-180046
The paper
Danborg, P. B., Valdersdorf, M., & Gøtzsche, P. C. (2019). Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review. International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/jrs-180046

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.